Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
180.00
+1.90 (1.07%)
Jun 30, 2026, 4:08 PM HKT

HKG:2637 Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, HKG:2637 stock has a consensus rating of "Strong Buy" and an average price target of $289.66. The average 1-year stock price forecast is 60.92% higher than the current stock price, while the lowest is $279.29 (+55.16%) and the highest is $300.04 (+66.69%).

Price Target: $289.66 (+60.92%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$279.29$289.66$289.66$300.04
Change+55.16%+60.92%+60.92%+66.69%

Analyst Ratings

The average analyst rating for HKG:2637 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '26Jun '26
Strong Buy12
Buy00
Hold00
Sell00
Strong Sell00
Total12

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Huafu Securities
No rating
Huafu Securities
Buy
Maintains
$264.30
BuyMaintains$264.30+46.83%Jun 14, 2026
CMB International Securities
CMB International Securities
Buy
Initiates
$280.00
BuyInitiates$280.00+55.56%Jun 10, 2026
Unknown Analyst
Northeast Securities
No rating
Northeast Securities
Buy
Maintains
$346.75
BuyMaintains$346.75+92.64%May 8, 2026
Unknown Analyst
Guohai Securities
No rating
Guohai Securities
Buy
Maintains
$339.55
BuyMaintains$339.55+88.64%May 7, 2026
Unknown Analyst
Shenwan Hongyuan
No rating
Shenwan Hongyuan
Buy
Maintains
$298.28
BuyMaintains$298.28+65.71%Apr 25, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
722.00M
from 582.36M
Increased by 23.98%
Revenue Next Year
850.00M
from 722.00M
Increased by 17.73%
EPS This Year
2.53
EPS Next Year
2.94
from 2.53
Increased by 16.21%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
212.47M316.63M466.68M582.36M722.00M
Revenue Growth
-49.03%47.39%24.79%23.98%
Gross Profit
172.07M263.64M387.19M485.56M599.26M
Gross Margin
80.99%83.26%82.97%83.38%83.00%
Operating Income
80.35M120.28M133.03M192.26M228.00M
EPS
----2.53
Forward PE
----61.63
Free Cash Flow
-59.52M-57.30M27.61M112.00M
No. Analysts
----2
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High751.0M
Avg722.0M
Low693.0M

Revenue Growth

Revenue Growth202620272028
High
29.0%
Avg
24.0%
Low
19.0%

EPS Forecast

EPS202620272028
High2.67
Avg2.53
Low2.39

EPS Growth

EPS Growth20272028
High
22.9%
Avg
16.2%
Low
9.5%